Narcolepsy Drugs Market : Industry Forecast, 2017-2023
Although narcolepsy is a rare and under-diagnosed chronic condition, there are many people affected by the disease. It was estimated that more than 1 in 2,000 people in the U.S. were affected by narcolepsy in 2012. The severity of the disease and rise in the number of people being affected by narcolepsy are some of the driving factors for the market growth. Furthermore, the availability of reimbursement for FDA-approved prescription medicines will help increase the demand for these drugs. However,...
View full press release